RecruitingPhase 1Phase 2NCT06381791

CBD for Pain Following Orthopedic Shoulder Surgery

Cannabidiol (CBD) As A Pain Adjunct in Orthopedic Surgical Patients: A Randomized Control Trial


Sponsor

The Methodist Hospital Research Institute

Enrollment

80 participants

Start Date

May 24, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of the study is to learn if Epidiolex (cannabidiol) works as a additional pain medication in patients who have had orthopedic shoulder surgery. It is also to learn about safe dosages and identify any side effects after surgery. Researchers will compare Epidiolex to a placebo solution to see if Epidiolex lowers pain after shoulder surgery. Participants will: * track their pain and what medications they use every day in a provided pain diary. A researchers will call every seven days to check on the participant and diary. * Complete two short surveys. Once before surgery and once after. * Have bloodwork tested after surgery


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Epidiolex and a drug called Placebo oral solution for people with shoulder osteoarthritis and rotator cuff injuries. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEpidiolex

150mg of Epidiolex

DRUGPlacebo oral solution

150mg of Placebo oral solution


Locations(1)

Houston Methodist Hospital

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06381791


Related Trials